From professional translators, enterprises, web pages and freely available translation repositories.
in de kras wild-type groep was de responsfrequentie 17% voor panitumumab en 0% voor bsc.
in the kras wild-type group the response rate was 17% for panitumumab and 0% for bsc.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
de responsfrequentie (naar oordeel van de onderzoeker) bij patiënten die overstapten naar panitumumab na progressie bij enkel bsc was 22% (95% ci:
response rate (investigator assessment) in patients that crossed over to panitumumab after progression on bsc alone was 22% (95% ci:
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
de cumulatieve responsfrequentie was hoger tijdens de open-labelfase bij de patiënten die twee opeenvolgende ozurdex-injecties kregen, vergeleken met patiënten die in de initiële fase geen ozurdex-injectie hadden ontvangen.
the cumulative response rates were higher throughout the open label phase in those patients receiving two consecutive ozurdex injections compared with those patients who had not received an ozurdex injection in the initial phase.
Last Update: 2017-04-26
Usage Frequency: 1
Quality: